Companies · Other Health Care

Kindbody, Inc.

NEW YORK · Other Health Care

Diligence memoA one-page analyst read on Kindbody, Inc. — recommendation, valuation, rhythm, risks.
$95.6M
Total raised · real
2
Rounds
0.4×
Latest step-up
Top 5%
Sector rank · raised
Series C
Latest stage · inferred · Fri Aug 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

Kindbody, Inc. looks fair against its niche peers and is at-risk on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Fair
  • Modeled value is 1.33× the median modeled value of Series C Other Health Care companies in 2022–2024 (47 peers) — value vs value, same stage and era.
  • Within the normal band (133% of peer median) for its niche.
At-risk
  • Last raise 3.9 yr ago; this sector typically re-raises about every 14 months.
  • Past due for a raise versus sector cadence — watch for distress or a bridge.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

Kindbody, Inc. is one of 5377 Other Health Care companies tracked from NEW YORK. By capital raised it ranks among the largest (ahead of 96% of sector peers), and among the largest by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
27
Investors (latest)
2021
Year incorporated
2022-08-19
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$250M$500M$750M$1.0BSeries B · 2022-02-08 Raised $25M (real) Modeled valuation $334M (est)$25M$334MSeries B2022Series B · 2022-02-08 Raised $29M (real) Modeled valuation $398M (est)$29M$398MSeries B2022Series C · 2022-08-19 Raised $66M (real) Modeled valuation $875M (est)$66M$875MSeries C2022Series B · 2022-08-19 Raised $27M (real) Modeled valuation $308M (est)$27M$308MSeries B2022+$29M+$66M+$27MCumulative $147M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Series B$24.6M · 2022
Series B extension$29.4M · 2022
Series C$66.2M · 2022
Bridge · Series C-stage$26.7M · 2022smaller follow-on

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed, Seed, Series A — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 40%.

Modeled valuation trajectory
$875.1M
Base estimate est.
$240.6M
Conservative case
$1.7B
Upside case
$441.4M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Ca $40M–$100M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Series B · modeled $334.0M · 2022-02-082022Series B · modeled $398.5M · 2022-02-08Series C · modeled $875.1M · 2022-08-19Series B · modeled $308.3M · 2022-08-192022
Model inputs · modeled:benchmark-stage-stepup-v1
15%
Dilution assumption
Implied ownership sold in the financing.
73%
Survival probability
55% low · 85% high
1.29×/yr
Annual markup
1.48×/yr upside case
3.9 yr
Elapsed time used
3.9 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
2 mo
Avg between rounds
$181.8M/yr
Capital velocity
4.4 yr
On record since
2022
First round
4
Rounds on file
How it compares to the market

Benchmarked against 5377 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 39× above median
This company$95.6M
Sector median$2.4M
Latest round — vs other Series C rounds in sector (real $, this stage) 0.6× of median
This company$26.7M
Sector median$45.9M
Modeled value — vs sector median (estimate, all stages) 40× above median
This company$875.1M
Sector median$22.1M

Raised more than 96% of sector peers (real $). Modeled value above 96% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series C) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #9 of 47.

This companyCohort peer
$100.0M$1.0B$10.0B$10.0M$100.0M$1.0BCapital raised (log)Gravie, Inc. · Series C Raised $160.7M · modeled $1.3B (est)EmpowerMe Holdings, LLC · Series C Raised $96.6M · modeled $1.3B (est)Color Holdings, L.P. · Series C Raised $90.9M · modeled $1.1B (est)RSR Senior Residences, LLC · Series C Raised $73.7M · modeled $1.1B (est)Gynesonics, Inc · Series C Raised $299.1M · modeled $1.0B (est)Hello Heart Inc. · Series C Raised $127.0M · modeled $1.0B (est)Beta Bionics, Inc · Series C Raised $277.5M · modeled $1.0B (est)BioDerm Holdings, LP · Series C Raised $130.9M · modeled $1.0B (est)Drconsulta Ltd. · Series C Raised $140.1M · modeled $837.3M (est)Fountain Life, LLC · Series C Raised $103.9M · modeled $828.2M (est)TherapyMatch, Inc. · Series C Raised $100.0M · modeled $809.2M (est)Kindbody, Inc. (this company) Raised $95.6M · modeled $875.1M (est)Kindbody, Inc.
CompanyStageRaised · realValue · estvs peer med.
Gravie, Inc.Series C$160.7M$1.3B2.04×
EmpowerMe Holdings, LLCSeries C$96.6M$1.3B1.92×
Color Holdings, L.P.Series C$90.9M$1.1B1.75×
RSR Senior Residences, LLCSeries C$73.7M$1.1B1.71×
Gynesonics, IncSeries C$299.1M$1.0B1.58×
Hello Heart Inc.Series C$127.0M$1.0B1.54×
Beta Bionics, IncSeries C$277.5M$1.0B1.54×
BioDerm Holdings, LPSeries C$130.9M$1.0B1.53×
Kindbody, Inc. this companySeries C$95.6M$875.1M1.33×
Drconsulta Ltd.Series C$140.1M$837.3M1.28×
Fountain Life, LLCSeries C$103.9M$828.2M1.26×
TherapyMatch, Inc.Series C$100.0M$809.2M1.23×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Series B$24.6M2022-02-08$136.7M$334.0M90%
Series B$29.4M2022-02-08$163.1M$398.5M90%
Series C$66.2M2022-08-19$441.4M$875.1M90%
Series B$26.7M2022-08-19$148.1M$308.3M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Series B$24.6M2022-02-08
    • First recorded raise — entered as Series B.
    • 25 investors on this round.
  2. Series B$29.4M2022-02-08
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
    • 45 investors on this round.
  3. Series C$66.2M2022-08-19
    • Came back fast: 6 mo vs the ~14 mo sector norm.
    • Round 2.3× larger than the prior — scaling up.
    • 41 investors on this round.
  4. Series B$26.7M2022-08-19
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 2.5× smaller than the prior — bridge or down round.
    • 27 investors on this round.
Intelligence
2022 ~Q4
Modeled next raise · ~2mo cadence
$26.7M
Modeled next size est.range $26.7M$42.7M
0.4×
Last step-up
$181.8M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Stuart Ellman17 other2022-02
Theresa Sexton6 other2022-02
Cheryl Pegus3 other2022-08
Gina Bartasi2 other2022-02
Kathy Harris2 other2022-02
Linda Mintz2 other2022-02
Annbeth Eschbach1 other2022-02
Ellen Hukkelhoven1 other2022-02
Angeline Beltsos, M.D.2022-02
Registry & provenance

Kindbody, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1913281
SEC CIK
2021
Incorporated
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
KBI Services, Inc.Other Health CareSeries C$84.2M$1.1Bnetwork5 shared operators · same sector · same stage
Auxogyn IncOther Health CareSeries B$73.1M$327.3Mnetwork3 shared operators · same sector
Recover Together, Inc.Other Health CareSeries C$102.5M$1.1Bnetwork1 shared operator · same sector · same stage
EmpowerMe Holdings, LLCOther Health CareSeries C$96.6M$1.3Bsame sector · same stage
Paradromics, Inc.Other Health CareSeries C$96.9M$570.0Msame sector · same stage
Aseko Inc.Other Health CareSeries B$75.9M$211.4Mnetwork1 shared operator · same sector
Moksha8 IncOther Health CareSeries C$93.5M$1.4Bsame sector · same stage
Element Science, Inc.Other Health CareSeries C$97.6M$1.2Bsame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Kindbridge CorpOther Health CareSeed$9.9M87%
Remedly, Inc.Other Health CarePre-Seed$26.1M84%
TearRestore, Inc.Other Health CarePre-Seed$15.4M83%
Kindful Health, LLCHospitals and PhysiciansSeries A$93.6M83%
BaseHealth, Inc.Other Health CareSeries A$91.7M83%
Mediphore, Inc.Other Health CareSeries A$302.7M83%
Somatus, Inc.Other Health CareSeries C$1.1B83%
Medable Inc.Other Health CareSeries D+$5.4B83%
Frequently asked
How much funding has Kindbody, Inc. raised?
Kindbody, Inc. has raised approximately $95.6M in disclosed capital across 2 recorded financing rounds, aggregated from public filings.
What is Kindbody, Inc.'s estimated valuation?
Provath's modeled valuation for Kindbody, Inc. is approximately $875.1M (modeled range $240.6M–$1.7B). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Kindbody, Inc. at?
Kindbody, Inc.'s latest modeled financing stage is Series C. Its most recent recorded round closed around Fri Aug 19.
What does Kindbody, Inc. do and where is it based?
Kindbody, Inc. operates in the Other Health Care sector, based in NEW YORK.
Explore related

See where Kindbody, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Kindbody, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.